Table 3.
Model 1 |
Model 2 |
Model 3 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Age, Alb, IgG |
Age, lung disease, BMI, Lymph, IgG |
Age |
|||||||||
GC (–) |
GC (+) |
||||||||||
GC (−) | GC (+) | Lung disease |
Lung disease |
GC (−) | GC (+) | ||||||
(−) | (+) | (−) | (+) | ||||||||
α | 2.5605 | −1.6494 | −7.9920 | −6.8932 | −3.7464 | −3.0594 | −9.9273 | −7.3780 | |||
β1 | (Age) | 0.0742 | 0.0375 | (Age) | 0.0756 | 0.0513 | (Age) | 0.0885 | 0.0556 | ||
β2 | (Alb) | −1.7572 | −0.9972 | (BMI) | 0.2044 | −0.1176 | |||||
β3 | (IgG) | −0.0038 | −0.0008 | (IgG) | −0.0028 | −0.0007 | |||||
β4 | (Lymph) | −0.0020 | −0.0001 |
The incidence of pneumocystis pneumonia (p) was calculated using the formula: Ln(α + β1 × Age + β2 × Alb + β3 × IgG. GC, concomitant glucocorticoid use; Alb, serum albumin (g/dl); IgG, serum IgG (mg/dl); Lymph, lymphocyte count (/μl).